We are monitoring the impact of COVID-19 on MEA Biobanks Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 447
Share on
Share on

Middle East and Africa Biobanks Market Research Report – Segmented By Product Type, Sample Type, Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends, Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 447
Pages: 138

MEA Biobanks Market Size (2021 to 2026)

The Biobanks Market in Middle East & Africa is expected to increase at a CAGR of 7.53% between 2021 to 2026. As a result, this market is forecasted to be worth USD 29.03 million by 2026 from USD 20.19 million in 2021.

Biobanks aid in the preservation of a patient's personal and medical information; nevertheless, the proper environment must be maintained to keep biological resources in biobanks. Furthermore, these specimens and data are utilized to diagnose and establish the causes of diseases. Single-nucleotide polymorphisms, for example, have been related to a variety of disorders.

The increasing R&D efforts to study diseases and the growing demand for cost-effective drug discovery and development are majorly driving the Biobanks market in Middle East Africa. In addition, the increasing number of biobanks and the availability of advancing healthcare sectors is expected to boost the market. Also, the rising number of bio-samples across the region increases the demand for the equipment. Furthermore, growing investments and funding by the government and private organizations for the development of healthcare infrastructure and to support regenerative medicine research encourage market growth. In addition, there has been an increasing trend of preserving cord blood stem cells from newborns in recent years, which is projected to generate attractive development opportunities for the market.

Furthermore, advances in regenerative medicine are projected to generate considerable growth opportunities for market players. Using stem cell technology, Regenerative medicine is one of the essential treatments for diseases such as Alzheimer's and chronic diseases such as diabetes, cancer, and uncommon genetic disorders. In addition, umbilical cord cells and other stem cells are preserved to benefit from existing therapies. The availability of numerous types of biospecimens to support a wide range of sectors, including drug research, diagnostics, and others, has accelerated biorepository diversification, boosting the biobanks market in MEA.

The high cost of automation and the issues related to the biospecimen sample procurement are restraining the market growth. In addition, stringent regulation on biobanks and various privacy policies are more likely to limit the development of the biobanks market in MEA. 

This research report on the MEA Biobanks market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Equipment
  • Consumables

By Sample Type: 

  • Human Tissues
  • Stem Cells
  • DNA Or RNA
  • Bio-fluids
  • Others

By Application: 

  • Therapeutic Applications
  • Research Applications
  • Clinical Trials

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The MEA recorded a moderate share in the worldwide biobanks market in 2020, and it is estimated to grow at a promising pace during the forecast period. The increasing prevalence of blood disorders and chronic conditions like cancer drive the market growth. In addition, availability of advancing healthcare infrastructure, increasing research and development activities, Supportive government policies. Further, personalized and regenerative medicine development in emerging countries such as South Africa, UAE, and Saudi Arabia contributes to regional market growth.

South Africa accounted for the largest share of the market, and it is anticipated to register a predominant share during the forecast period. The increasing research and development activities, high healthcare spending, and technological advancements in the healthcare sector are expected to boost the market growth.

Further, emerging countries such as UAE and Saudi Arabia are predicted to record a considerable share in the market. The prevalence of chronic disorders, the growing geriatric population, changing lifestyles, and supportive government policies contribute to market growth.

KEY MARKET PLAYERS:

Companies dominating the MEA Biobanks Market profiled in this report are Beckman Coulter, Tecan group, Taylor- Wharton, Panasonic biomedical, Teva Pharmaceuticals, Biolife Solutions, Custom biogenic systems, Princeton cryotech, Fluidx, Tissue solutions, Wildcat laboratory solutions, Micronik and Brooks life science systems.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 By Product Type                                       

                                5.1.1 Equipment’s                           

                                                5.1.1.1 Temperature control systems     

                                                5.1.1.2 Incubators           

                                                5.1.1.3 Centrifuges         

                                                5.1.1.4 Alarm and Monitoring Systems  

                                                5.1.1.5 Accessories         

                                                5.1.1.6 Other Equipment's          

                                5.1.2 Consumables                         

                5.2 By Sample Type                                        

                                5.2.1 Human Tissues                      

                                5.2.2 Stem Cells               

                                5.2.3 DNA or RNA                            

                                5.2.4 Bio-fluids                 

                                5.2.5 Other Sample Type                             

                5.3 By Application                                           

                                5.3.1 Therapeutic Applications                  

                                5.3.2 Research Applications                        

                                5.3.3 Clinical Trials                           

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                6.2 Middle-East                                                

                6.3 Africa                                            

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Beckman Coulter                                     

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Tecan group                                               

                8.3 Taylor- Wharton                                       

                8.4 Panasonic biomedical                                             

                8.5 Teva pharmaceuticals                                            

                8.6 Biolife solutions                                        

                8.7 Custom biogenic systems                                     

                8.8 Princeton cryotech                                  

                8.9 Fluidx                                            

                8.10 Tissue solutions                                      

                8.11 Wildcat laboratory solutions                                             

                8.12 Micronik                                    

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Bio Bank Market, By Region, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Bio Bank Market, By Product Type, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Equipment's Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Equipment's Market, By Equipment Type, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Temperature control systems Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Incubators Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Centrifuges Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Alarm and Monitoring Systems Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Accessories Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Other Equipment's Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Consumables Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Bio Bank Market, By Sample Type, From 2021 to 2026 (USD Million)
  13. Middle East & Africa Human Tissues Market, By Region, From 2021 to 2026 (USD Million)
  14. Middle East & Africa Stem Cells Market, By Region, From 2021 to 2026 (USD Million)
  15. Middle East & Africa DNA or RNA Market, By Region, From 2021 to 2026 (USD Million)
  16. Middle East & Africa Bio-fluids Market, By Region, From 2021 to 2026 (USD Million)
  17. Middle East & Africa Other Sample Type Market, By Region, From 2021 to 2026 (USD Million)
  18. Middle East & Africa Bio Bank Market, By Application, From 2021 to 2026 (USD Million)
  19. Middle East & Africa Therapeutic Applications Market, By Region, From 2021 to 2026 (USD Million)
  20. Middle East & Africa Research Applications Market, By Region, From 2021 to 2026 (USD Million)
  21. Middle East & Africa Clinical Trials Market, By Region, From 2021 to 2026 (USD Million)
  22. Middle East Bio Bank Market, By Product Type, From 2021 to 2026 (USD Million)
  23. Middle East Equipment's Market, By Equipment Type, From 2021 to 2026 (USD Million)
  24. Middle East Bio Bank Market, By Sample Type, From 2021 to 2026 (USD Million)
  25. Middle East Bio Bank Market, By Application, From 2021 to 2026 (USD Million)
  26. Africa Bio Bank Market, By Product Type, From 2021 to 2026 (USD Million)
  27. Africa Equipment's Market, By Equipment Type, From 2021 to 2026 (USD Million)
  28. Africa Bio Bank Market, By Sample Type, From 2021 to 2026 (USD Million)
  29. Africa Bio Bank Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample